Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study

• Asıl Yazarlar: Yong-Shuai Wang (Yazar), Wei Wang (Yazar), Sai Zhang (Yazar), Shen-Yu Zhang (Yazar), Ai-Zong Shen (Yazar), Hua-Chuan Song (Yazar), Huan-Zhang Yao (Yazar), Rui-Peng Song (Yazar), Fan-Zheng Meng (Yazar), Lei Li (Yazar), Bjoern Nashan (Yazar), Ji-Zhou Wang (Yazar), Lian-Xin Liu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Purpose: To investigate the clinical efficacy of avatrombopag, an oral thrombopoietin receptor agonist, versus subcutaneous recombinant human thrombopoietin (rh-TPO) in the treatment of severe thrombocytopenia (TCP) associated with chronic liver disease (CLD).Methods: Clinical data of 250 patients w...